Back to Global NewsPublished: 25 Feb 2026Download AppJoin TelegramWhy Alpha Tau's Japan Approval Could Redefine Cancer Immunotherapy: Your Portfolio May Benefit#Alpha Tau Medical#Cancer Immunotherapy#Radiation Therapy#Checkpoint Inhibitors#Medical Devices#Japan Approval#Biotech StocksDownload AppJoin CommunityShare Article